Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVLN

Avalyn Pharma Inc

May 01 • 04:00PM ET

29.84

+0.35 1.19 %

Healthcare • Biotechnology • USA • Small • NASD

Today, 4:05 PMAvalyn Pharma closes IPO with full overallotment exercise, raising $345 million in gross proceeds at $18 per share

Held by: TMSL TMED

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	36.95M	Perf Week	-
Market Cap	1.10B	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	1.19%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	30.20 -1.19%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	26.00 14.77%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	3.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	0.59%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	0.59%	Rel Volume	0.13	Prev Close	29.49
Employees	50	LT Debt/Eq	-	Earnings	-	SMA200	0.59%	Avg Volume	6.51M	Price	29.84
IPO	Apr 30, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	829,832	Change	1.19%

Today 04:01PM

Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

(GlobeNewswire)

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carroll Jill	Director	May 01 '26	Buy	18.00	277,778	5,000,004	2,186,562	May 01 06:50 PM
SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	May 01 '26	Buy	18.00	555,555	9,999,990	2,186,562	May 01 06:46 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AVLN

Avalyn Pharma Inc

Upgrade your Finviz experience